Carsten Bokemeyer
Impact in
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies
- Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies
Papers in
- Co-authors
- Hans‐Joachim Schmoll (91 shared papers)Lothar Kanz (89 shared papers)Karin Oechsle (109 shared papers)Christian Kollmannsberger (70 shared papers)Friedemann Honecker (79 shared papers)J.T. Hartmann (38 shared papers)Gunter Schuch (27 shared papers)Guido Sauter (49 shared papers)
- Journals
- Journal of Clinical Oncology (105 papers)Annals of Oncology (57 papers)Blood (35 papers)European Journal of Cancer (29 papers)British Journal of Cancer (23 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Carsten Bokemeyer
908 papers receiving 35.7k citations
Carsten Bokemeyer's Hit Papers
Peers
Comparison fields: 5 of 173
- Oncology 11.1k
- Otorhinolaryngology 1.5k
- Hematology 3.6k
- Surgery 9.8k
- Pulmonary and Respiratory Medicine 6.8k
Countries citing papers authored by Carsten Bokemeyer
This map shows the geographic impact of Carsten Bokemeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Bokemeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Bokemeyer more than expected).
Fields of papers citing papers by Carsten Bokemeyer
This network shows the impact of papers produced by Carsten Bokemeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Bokemeyer. The network helps show where Carsten Bokemeyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Carsten Bokemeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 961 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer Hit paper breakdown → | 2008 | 2620 |
| 2 | Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 1248 |
| 3 | The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients Hit paper breakdown → | 2004 | 687 |
| 4 | Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study Hit paper breakdown → | 2011 | 613 |
| 5 | Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie Hit paper breakdown → | 2008 | 576 |
| 6 | POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Hit paper breakdown → | 2003 | 502 |
| 7 | Guidelines on Testicular Cancer: 2015 Update Hit paper breakdown → | 2015 | 460 |
| 8 | Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials Hit paper breakdown → | 2012 | 447 |
| 9 | The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial Hit paper breakdown → | 2010 | 408 |
| 10 | 2006 | 377 | |
| 11 | 2002 | 301 | |
| 12 | 2009 | 300 | |
| 13 | 2008 | 288 | |
| 14 | 2012 | 287 | |
| 15 | 2006 | 280 | |
| 16 | 2011 | 267 | |
| 17 | 2005 | 262 | |
| 18 | 1998 | 251 | |
| 19 | 2004 | 237 | |
| 20 | 2004 | 236 |
About Carsten Bokemeyer
Carsten Bokemeyer is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Hematology, having authored 961 papers that have together received 36.5k indexed citations. Recurring topics across this work include Testicular diseases and treatments (209 papers), Colorectal Cancer Treatments and Studies (99 papers), Multiple Myeloma Research and Treatments (67 papers), Lung Cancer Treatments and Mutations (60 papers), Cancer Treatment and Pharmacology (49 papers), Cancer therapeutics and mechanisms (44 papers), Sarcoma Diagnosis and Treatment (32 papers) and Neuroblastoma Research and Treatments (31 papers). The work is most often cited by research in Oncology (11.1k citations), Otorhinolaryngology (1.5k citations), Hematology (3.6k citations), Surgery (9.8k citations) and Pulmonary and Respiratory Medicine (6.8k citations). Carsten Bokemeyer has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hans‐Joachim Schmoll, Lothar Kanz, Karin Oechsle, Christian Kollmannsberger, Friedemann Honecker, J.T. Hartmann, Gunter Schuch, Guido Sauter, Leendert H. J. Looijenga and P. Koralewski. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, European Journal of Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.